Domača stranDVA • NYSE
add
Davita Inc
Prejšnji trg. dan.
144,57 $
Dnevni razpon
145,02 $ - 147,77 $
Letni razpon
101,00 $ - 159,42 $
Tržna kapitalizacija
9,83 mrd. USD
Povprečni obseg
828,61 tis.
Razm. P/E
15,47
Dividendna donosnost
-
Primarna borza
NYSE
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 3,62 mrd. | 9,87 % |
Stroški poslovanja | 659,06 mio. | 11,97 % |
Čisti dohodek | 234,22 mio. | −9,68 % |
Čista dobičkovnost prihodkov | 6,47 | −17,79 % |
Earnings per share | 3,40 | 51,79 % |
EBITDA | 737,91 mio. | 12,69 % |
Efektivna davčna stopnja | 20,05 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 700,74 mio. | −17,17 % |
Skupna sredstva | 17,48 mrd. | 1,13 % |
Skupne obveznosti | 16,32 mrd. | 7,42 % |
Celoten lastniški kapital | 1,16 mrd. | — |
Shares outstanding | 66,80 mio. | — |
Razmerje P/B | −15,22 | — |
Donosnost sredstev | 7,87 % | — |
Donosnost kapitala | 9,79 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 234,22 mio. | −9,68 % |
Denar iz dejavnosti | 540,73 mio. | −1,26 % |
Denar iz naložb | −163,13 mio. | 34,22 % |
Denar iz financiranja | −414,52 mio. | 26,65 % |
Neto sprememba denarnih sredstev | −37,67 mio. | 86,49 % |
Prost denarni tok | 395,96 mio. | 16,37 % |
Vizitka
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
Generalni direktor
Datum ustanovitve
1992
Sedež organizacije
Spletno mesto
Zaposleni
78.000
